Next Article in Journal
The Bog Bilberry Enigma: A Phytochemical and Ethnopharmacological Analysis of Vaccinium uliginosum L. Fruits in Regard to Their Alleged Toxicity
Previous Article in Journal
Physiological Mechanisms of Exogenous ABA in Alleviating Drought Stress in Nitraria tangutorum
Previous Article in Special Issue
Growth-Promoting Effects of Ten Soil Bacterial Strains on Maize, Tomato, Cucumber, and Pepper Under Greenhouse Conditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens

1
Microbial Processes and Interactions (MiPI) Laboratory, TERRA Teaching and Research Centre, Gembloux Agro-Bio Tech, University of Liège, B-5030 Gembloux, Belgium
2
College of Plant Protection, Shandong Agricultural University, Taian 271028, China
*
Authors to whom correspondence should be addressed.
Plants 2025, 14(17), 2644; https://doi.org/10.3390/plants14172644
Submission received: 9 July 2025 / Revised: 19 August 2025 / Accepted: 20 August 2025 / Published: 25 August 2025
(This article belongs to the Special Issue Advances in Microbial Solutions for Sustainable Agriculture)

Abstract

Cyclic lipopeptides (CLPs) are secondary metabolites produced by plant-beneficial bacteria, including Bacillus, Pseudomonas, Paenibacillus, Burkholderia, Serratia, and Streptomyces species. Of these bacterial sources, CLPs from Bacillus and Pseudomonas have been studied most extensively for their role in plant immunity, particularly in mediating induced systemic resistance. With this review, we provide a unique and comprehensive survey of CLPs from plant-beneficial bacteria described for this function. We consolidate existing knowledge on their role in triggering induced systemic resistance across various plant–pathogen systems and elucidate the underlying mechanisms of symptom suppression. We also discuss the need for further mechanistic studies, but also for implementing each step of the process, leading to marketable CLP-based products used as alternatives to chemicals in sustainable agriculture.

1. Introduction

As sessile organisms, plants are particularly vulnerable to environmental threats and have evolutionarily adapted by recruiting plant-beneficial bacteria (PBB) from soil microbiomes. These microbial partners function as biocontrol agents and enhance host resilience via two principal mechanisms, including direct antagonism through the inhibition or elimination of phytopathogens, as well as induction of systemic immune responses that prime the plant for enhanced defense [1,2]. The latter leads to enhanced resistance against subsequent infections, a phenomenon known as induced systemic resistance (ISR). Among PBB, Pseudomonas spp. produce a range of small-sized compounds (also referred to as Bioactive Secondary Metabolites, BSMs) that contribute to biocontrol by mediating complex interactions among plants, pathogens, and antagonists. Key BSMs involved in these interactions include phenazines, phloroglucinols, pyoluteorins, pyrrolnitrins, CLPs, hydrogen cyanide, and volatile organic compounds such as nunamycin and nunapeptin [3]. Bacillus spp. produce BSMs, including nonribosomally synthesized compounds (e.g., oligopeptides, CLPs, and polyketides) as well as post-translationally modified molecules such as lanthipeptides and bacteriocins. CLPs are particularly interesting and serve as versatile mediators of biocontrol, exhibiting both direct antimicrobial properties and the ability to elicit ISR in plants [4,5,6,7]. Beyond their protective functions, CLPs also play an essential ecological role by supporting bacterial survival and facilitating interactions with other organisms in their environment [8].
In this review, we first briefly characterize CLPs produced by PBB, covering their chemical structures and established biological functions. We then focus specifically on their role as elicitors of ISR in plants. As other metabolites with ISR-inducing activity can be co-produced by bacteria, definitive confirmation of this specific function for CLPs requires the utmost care and strong experimental evidence. This must involve either studies showing loss of function in CLP-deficient mutant strains compared to the wild type and/or bioassays showing systemic resistance induced upon treatment with CLP compounds isolated from bacterial crude extracts, but with sufficient and proven purity (HPLC-purified). Importantly, we exclusively considered studies reporting a clear physical separation between CLPs and pathogens, thereby clearly demonstrating ISR rather than direct antagonism. Common experimental designs include root pretreatment with CLPs or bacterial strains followed by leaf pathogen challenge (using either seedlings or detached leaves), local leaf treatment with CLPs/bacteria followed by distal leaf pathogen inoculation, or soil-based root treatment with subsequent stem pathogen application. For studies deviating from these approaches, demonstration of negative direct antagonism (as in references [9,10]) is required to confirm ISR activity. We also exclusively consider studies that investigate CLP activity at physiologically relevant concentrations (a low micromolar range), thereby reflecting natural biological conditions.
This review provides a comprehensive analysis of CLP-induced ISR through multiple perspectives: structural characteristics and effective concentrations of CLPs; susceptible plant and pathogen species; and current understanding of perception mechanisms. We specifically address CLP-mediated ISR across diverse plant systems. We highlight the untapped potential of these compounds and advocate for intensified research efforts to fully characterize CLP properties for sustainable agricultural applications.

2. CLP Biosynthesis

CLPs are produced through nonribosomal peptide synthetases (NRPSs). These multi-modular enzyme complexes are encoded by well-characterized giant biosynthetic gene clusters (BGCs) [11,12], which have been identified and characterized in Bacillus and Pseudomonas species [13]. NRPSs function as sophisticated molecular assembly lines, incorporating amino acid (AA) residues and facilitating various cyclization reactions [12]. The NRPS architecture typically comprises several functional domains: adenylation (A) activates AA substrates; the thiolation/peptidyl carrier protein (T/PCP) transports growing peptide chains; condensation (C) catalyzes peptide bond formation; starter condensation (Cs) mediates lipid–peptide conjugation at the N-terminus; epimerization (E) converts L- to D-AAs; and thioesterase (TE) terminates elongation and facilitates cyclization [14,15,16] (Figure 1). The CLP biosynthetic pathway involves three key stages: precursor activation, sequential peptide chain elongation with concurrent FA incorporation, and final export of the mature metabolite [17]. For most strains, CLPs are biosynthesized exclusively through NRPS-mediated thiotemplate mechanisms [18]. However, Bacillus species employ distinct pathways for different CLP families: the Surfactin and Fengycin families, containing β-hydroxy FAs, are produced by dedicated NRPS systems; the iturin family, characterized by β-amino FAs, is synthesized via a polyketide synthase (PKS)–NRPS hybrid pathway [19]. The locillomycin biosynthetic machinery also employs a PKS-NRPS hybrid complex that substitutes the canonical Cs domain with an integrated PKS acyl ligase (AL) domain for FA incorporation [20].

3. Diversity of CLP Structures and Functions

PBBs represent a phylogenetically diverse group of rhizosphere-associated microorganisms that promote crop productivity. Major PBB genera include Bacillus, Pseudomonas, Acetobacter, Azospirillum, Paenibacillus, Serratia, Burkholderia, Herbaspirillum, Rhodococcus, Actinobacteria, and Lactobacillus [21]. Many PBBs can produce CLPs, but this review primarily focuses on CLPs from Bacillus and Pseudomonas spp., which are by far the best described (Table 1 and Figure 2).

3.1. Bacillus CLPs

Bacillus-derived CLPs are classified into three main families: Surfactins (including surfactin, pumilacidin, lichenysin, bamilocyn, and halobacilin), Fengycins (fengycin/plipastatin and maltacin), and Iturins (iturin, mycosubtilin, bacillomycin, mojavensin, mixirins, and bacillopeptins) [22,23,24]. Additional structurally distinct CLPs include kurstakin, locillomycin, antiadhesin, circulocin, and licheniformin [24]. These compounds exhibit variations in both their FA moieties (ranging from β-hydroxy to β-amino forms, with either ester or amide linkages) and their cyclic peptide structures (comprising 5–10 AA residues in various L/D configurations) [24]. The β-hydroxy-type CLPs, including surfactin, fengycin, kurstakin, antiadhesin, bamylocin A, circulocin, and locillomycin, predominantly feature ester bonds, while β-amino-type compounds like iturin and licheniformin contain characteristic amide linkages. Notably, some CLPs such as circulocins incorporate unusual guanylated FA chains [24]. Functionally, each CLP family displays distinct antimicrobial profiles. Surfactins exhibit some limited activity against both bacteria and fungi, while iturins and fengycins demonstrate particularly potent antifungal properties [23,25].

3.2. Pseudomonas CLPs

CLPs produced by Pseudomonas species can be categorized based on whether they are derived from beneficial strains (plant growth-promoting rhizobacteria or biocontrol agents) or pathogenic strains (phytopathogens). This division highlights the dual roles of Pseudomonas CLPs, either as biocontrol tools in sustainable agriculture or as virulence determinants in plant diseases, depending on the ecological nature of the producing strain [26].
Beneficial Pseudomonas strains, such as P. fluorescens, P. putida, and P. protegens, produce CLPs that contribute to biocontrol, biofilm formation, and plant growth promotion [27]. These include the viscosin group (e.g., viscosin, viscosinamide, massetolide, WLIP, pseudodesmin, and pseudophomin), the amphisin group (e.g., lokisin/anikasin, milkisin/stechlisin/tensin, arthrofactin, pholipeptin, amphisin, oakridgin, and nepenthesin), and the bananamide group (e.g., bananamide A-G, MDN-0066, and prosekin) [27]. Additional CLPs from beneficial strains include orfamide, putisolvin, gacamide, xantholysin, entolysin, and cocoyamide, which exhibit antimicrobial and surfactant properties that support their role in microbial competition and root colonization [26,27,28].
In contrast, pathogenic Pseudomonas strains, such as P. syringae, P. tolaasii, and P. corrugata, produce CLPs that function as virulence factors that promote host cell lysis through pore formation, disrupting host cell membranes and promoting disease [28]. Pathogenic Pseudomonas CLPs primarily belong to the Mycin (e.g., syringotoxin) and Peptin (e.g., fuscopeptin) families [28]. The syringomycin group (e.g., syringomycin, syringostatin, pseudomycin A, cormycin A, syringafactin, cichofactin, virginiafactin, and thanamycin) is particularly notable for its phytotoxic effects [27]. Similarly, the tolaasin group (e.g., tolaasin, sessilin, corpeptin, and FP-B) induces necrosis in plants, and the poaeamide group (e.g., PPZPM and poaeamide A) is associated with pathogenic P. poae [27].

3.3. CLPs from Other Bacterial Genera

Besides Bacillus and Pseudomonas species, numerous soil-dwelling bacteria that contribute to plant health and ecological adaptation also produce CLPs. Among these, Paenibacillus-derived CLPs exhibit remarkable structural and functional diversity. Fusaricidin, a non-cationic lipopeptide, features a hexapeptide ring with both ester and amide linkages, along with a guanidinylated β-hydroxy FA moiety [29,30]. Structural variations among fusaricidins arise from AA substitutions at three positions within the peptide ring, conferring activity against fungi and Gram-positive bacteria [30]. Paenibacillus also produces cationic CLPs, including the polymyxin family (polymyxin/colistin A, B, C, D, E; mattacin/M; P, S, T), which vary in AA composition at specific residue positions; octapeptins (e.g., battacin) that exhibit broad-spectrum antimicrobial activity with reduced toxicity; the 13-AA-residue paenibacterin that disrupts both outer and cytoplasmic membranes; and other structurally distinct cationic CLPs such as polypeptins (e.g., pelgipeptin), paenibacterin, and gavaserin [30,31,32]. Notably, octapeptins demonstrate efficacy against both Gram-negative and Gram-positive bacteria through mechanisms distinct from classical polymyxins [30,31,32].
Serratia species synthesize structurally distinct CLPs, primarily from the Serrawettin family (serratamolide A to G; serrawettin W2 to W3). Serratamolide A (serrawettin W1) features a symmetric dilactone structure with two β-hydroxy FAs linked to two AAs (L-Ser1-L-Ser2), displaying antitumor, antimicrobial, and plant-protective properties [33,34,35]. Structural variations among serrawettin homologs (serratamolide B–G) arise from FA chain lengths (C8-C14) and unsaturation patterns [33]. In contrast, serrawettin W2 contains a pentapeptide core (D-Leu1-L-Ser2-L-Thr3-D-Phe4-L-Ile5) [33]. The stephensiolide family (A–K), originally identified from mosquito-associated Serratia sp., combines antibiotic activity with roles in bacterial motility. Genomic analyses suggest that these compounds may facilitate ecological niche colonization [36].
Actinomycetia-class bacteria represent a significant source of structurally diverse CLPs with notable bioactivities. Kitasatospora cystarginea produces cystargamides, characterized by a hexapeptide ring linked to an unusual 2,3-epoxy FA (C10) chain. Notably, cystargamide B has emerged as a promising lead compound for dengue fever treatment [37]. Actinoplanes species synthesize ramoplanin, a lipoglycodepsipeptide antibiotic featuring a 16-AA cyclic peptide conjugated to C8-C10 FA, demonstrating potent activity against Gram-positive bacteria [38]. Streptomyces species exhibit remarkable biosynthetic capacity and produce numerous CLPs including the clinically approved antibiotic daptomycin (Cubicin®) containing a 13-AA cyclic structure, some calcium-dependent antibiotics (CDAs; A54145), and other structurally distinct compounds (amphomycin, laspartomycin, and arylomycins) [38,39,40].

4. CLPs as Inducers of Plant-Species-Dependent ISR

Bacillus-derived CLPs from the Surfactin, Fengycin, and Iturin families demonstrate varying capacities in activating ISR depending on both the host plant and challenging pathogen. Among them, surfactin is the most well studied for triggering ISR in many plants, especially dicotyledons, such as in bean, tomato, grapevine, Arabidopsis, and tobacco against Botrytis cinerea; in melon against Podosphaera fusca; in strawberry against Colletotrichum gloeosporioides; in peanut against Sclerotium rolfsii and Athelia rolfsii; and in Arabidopsis against Pseudomonas syringae [9,41,42,43,44,45,46,47,48,49,50,51]. Notably, comparative studies reveal functional specialization among CLP families. In melon plants, fengycin and iturin mutants fail to induce ISR against Podosphaera fusca, unlike surfactin [42]. A parallel response is observed in grapevine plants, where plipastatin (a Fengycin-family CLP) does not trigger ISR against Botrytis cinerea, contrasting with surfactin’s activity [9].
Fengycin has also been demonstrated to induce ISR in multiple plant systems, such as in tomato against Botrytis cinerea, in Arabidopsis against Pseudomonas syringae, and in Chinese cabbage against Plasmodiophora brassicae [41,46,52,53]. Similarly, the Iturin-family CLPs (iturin and bacillomycin) exhibit ISR-eliciting activity across diverse hosts: iturin mediates protection in strawberry against Colletotrichum gloeosporioides, chili pepper against Phytophthora capsici, and Arabidopsis against Pseudomonas syringae [44,50,54], while bacillomycin induces ISR in Arabidopsis against both Pseudomonas syringae and Botrytis cinerea [46]. Intriguingly, in the rice–Pyricularia oryzae pathosystem, synergistic application of fengycin and iturin (with or without surfactin) is required for ISR induction, independent of soil conditions (acid sulfate or healthy potting soil) [55].
The induction of systemic resistance by CLPs exhibits some host specificity. While 5 µM surfactin effectively triggers ISR in bean plants against Botrytis cinerea and in peanut plants against Sclerotium rolfsii [41,47], this concentration fails to induce resistance in tomato plants against Botrytis cinerea [49]. Notably, fengycin demonstrates complementary activity patterns, showing no ISR induction in bean plants regardless of application method (using either fengycin-overproducing strains or a 5 µM purified compound), but effectively priming resistance in tomato plants when applied via fengycin-deficient bacterial strains [41]. Consistent with the existing literature, data reveal surfactin’s unique role as the only tested lipopeptide capable of eliciting ISR against Podosphaera fusca in melon, distinguishing it from fengycin and iturin [42]. Together, these results highlight the complex interplay between combinations of CLP structure and the host plant’s pathogen in determining ISR efficacy.
Current research demonstrates that Pseudomonas-synthesized CLPs can elicit ISR in a highly pathosystem-dependent manner. Massetolide A primes tomato defenses against Phytophthora infestans infection [56], while sessilin and orfamide, either individually or in combination, induce protective responses in bean plants challenged with Rhizoctonia solani [57]. Striking specificity is observed in rice systems, where orfamide confers resistance to Cochliobolus miyabeanus but not Magnaporthe oryzae, and the structurally distinct CLP WLIP shows opposing selectivity against Magnaporthe oryzae [58,59]. These findings collectively underscore that CLP-mediated ISR activation depends critically on precise molecular recognition events between specific CLP structures and particular plant–pathogen combinations. Table 2 shows CLPs from Bacillus and Pseudomonas species eliciting ISR across diverse plant–pathogen systems.

5. Differential Activation of ISR by CLPs Across Concentration Gradients

The capacity of CLPs to elicit ISR exhibits striking concentration dependence and structural specificity. In Arabidopsis thaliana, surfactin demonstrates pathogen-specific activation thresholds that 1 µM suffices for protection against Botrytis cinerea but fails against Pseudomonas syringae, while intermediate concentrations (2–16 µM) are effective against the bacterial pathogen Pseudomonas syringae, but higher concentrations at 32 µM are not [45,50]. Most studies report optimal ISR induction at 10 µM for surfactin across diverse pathosystems, including in melon plants against Podosphaera fusca, in Arabidopsis, tobacco, grapevine plants against B. cinerea, and in peanut plants against Sclerotium rolfsii and Athelia rolfsii [9,42,45,47,48,51]. There is thus a clear concentration–response relationship. While 5 µM surfactin is ineffective in tomato plants, 25 µM provides protection against Botrytis cinerea [49]. Similar dose–responses occur with other CLPs like orfamide, requiring more than 25 µM for ISR in rice plants against Cochliobolus miyabeanus [58]. Iturin shows a narrow effective window (0.5–2 µM) in Arabidopsis against Pseudomonas syringae, unlike at a lower concentration of 0.25 µM and a higher concentration of 4 µM [50]. Higher iturin concentrations (10 µM) are needed to trigger ISR in strawberry infected with Colletotrichum gloeosporioides [44]. These findings highlight our limited understanding of how CLP structural features govern ISR activation. The concentration-dependent effects and pathogen-specific induction patterns imply the existence of a sophisticated perception mechanism that requires further molecular characterization.

6. Synergistic Relationship of CLP Application Triggering ISR in Plants

Growing evidence indicates that different CLPs can act synergistically to enhance their biological functions. While single CLP-mediated ISR has been well-documented, recent studies highlight the effect of CLP combinations in modulating plant immune responses. For instance, iturin and surfactin cooperate to promote robust biofilm formation [60], while mixtures of fengycin and surfactin induce stronger ISR in bean plants against B. cinerea than either CLP alone [41]. Similarly, when combined, sessilin and orfamide exhibit synergistic activity against Rhizoctonia solani in bean plants [57].
ISR induction in rice plants against Pyricularia oryzae strictly requires the combined application of fengycin and iturin, irrespective of soil conditions [55]. Notably, surfactin that fails to trigger ISR alone potentiates the effect of fengycin–iturin mixtures, revealing complex higher-order interactions among CLPs [55]. These observations challenge the traditional single-component view of CLP activity and instead suggest that natural CLP mixtures may function cooperatively to elicit immune responses beyond what individual compounds can achieve.
Such synergistic effects underscore the ecological relevance of CLP diversity in rhizosphere communities and highlight the need to reconsider biocontrol strategies using rationally designed CLP combinations. However, the molecular mechanisms underlying these interactions remain poorly understood, emphasizing a key gap in our knowledge of how these microbial metabolites collectively shape plant immunity.

7. Molecular Mechanisms of CLP Recognition in Plants

Plants detect microbial presence through plasma membrane-localized pattern recognition receptors (PRRs) that perceive conserved microbial-associated molecular patterns (MAMPs), initiating pattern-triggered immunity (PTI) [61]. In contrast to this direct defense response, PBBs typically induce a more subtle priming ISR to enhance readiness for future pathogen challenges without immediate metabolic costs. While PTI triggers rapid, energy-intensive defense responses, ISR-mediated priming provides targeted protection that activates fully only upon subsequent pathogen recognition. This distinction is exemplified by surfactin’s mode of action in Arabidopsis thaliana. Unlike classical MAMPs (e.g., flagellin), surfactin neither elicits reactive oxygen species (ROS) bursts nor strongly upregulates defense-related genes during initial perception [45]. Instead, it establishes a primed state that enables amplified defense responses upon actual pathogen encounter.
The biological activity of CLPs stems from their specific interactions with cell membrane components. As amphiphilic molecules, CLPs spontaneously integrate into plasma membranes, whose complex structures are composed of phospholipids, sphingolipids, and sterols, through thermodynamically favorable hydrophobic interactions [62,63]. These interactions exhibit remarkable structural specificity that governs CLP bioactivities and their immune-modulating effects. Mycosubtilin demonstrates selective affinity for ergosterol in fungal membranes [64], while surfactin is preferentially incorporated into phospholipid bilayers, inducing subtle membrane perturbations rather than outright disruption. This delicate structural modulation appears sufficient to initiate downstream signaling cascades culminating in ISR [4,41,48,65,66]. Fengycins, by contrast, exert their effects through more generalized alterations of membrane architecture and permeability [41,65]. Structure–activity studies reveal critical determinants of CLP functionality. The bioactivity of iturin derivatives depends on both the integrity of their cyclic peptide structure and their FA chain composition, as demonstrated in Arabidopsis thaliana [67]. Similarly, among surfactin homologs, those with longer FA chains (C14-C15) show superior immune-stimulating capacity in tobacco cells compared to shorter chain variants (C12-C13) or structurally modified derivatives (linearized or methylated peptides) [68]. These in vitro observations highlight the exquisite structure–function relationships governing CLP activity, though their physiological relevance requires further validation in plants.
The biological activity of CLPs is fundamentally governed by their unique structural architecture. Cyclization of the peptide backbone confers enhanced molecular stability [69] and is essential for optimal bioactivity, as demonstrated by the consistently reduced efficacy of linear analogs. This structural requirement reflects the critical importance of three-dimensional conformation for target engagement, where the precise spatial arrangement of functional groups determines interaction specificity. CLP–membrane interactions exhibit remarkable structural selectivity based on several key physicochemical parameters. The amphipathic character of these molecules, dictated by FA chain length (typically C12-C15), branching patterns, and peptide ring composition (including AA stereochemistry), collectively determines their membrane insertion dynamics and subsequent biological effects [62]. These structure–activity relationships explain why subtle modifications, such as methylation or linearization of the peptide chain, can significantly alter immune-stimulating capacity [68]. However, further investigation is required to better understand the impact of the chemical structure of CLPs on their ISR functionality. For instance, additional structural analogs with variations in the peptide sequence should be tested. Interestingly, fluorinated CPL analogs display enhanced antimicrobial activity, and such derivatives could be tested for ISR [70,71].
Recent mechanistic studies have revealed unconventional perception pathways for certain CLPs. Surfactin’s dose-dependent activity in the micromolar range, coupled with its ability to modulate membrane fluidity without receptor binding, suggests a lipid-driven signaling mechanism [68]. This is further supported by its newly identified role in regulating miR846-mediated jasmonic acid signaling [72], representing a novel interface between membrane biophysics and transcriptional reprogramming. However, significant knowledge gaps remain in our understanding of CLP-mediated immunity. The molecular sensors responsible for CLP detection in plants have not been fully characterized, and the downstream signaling networks connecting membrane perturbations to systemic responses remain poorly mapped [41,65]. Furthermore, the translation of in vitro structure–activity relationships to whole-plant systems requires rigorous validation, particularly regarding concentration thresholds and tissue-specific effects.

8. Conclusions

CLPs demonstrate remarkable environmental stability, maintaining their structural and functional integrity under extreme temperature, salinity, and pH conditions [17]. While their role as plant immunity elicitors has been established, the current research landscape reveals significant geographical and taxonomic biases. Studies on Bacillus-derived CLPs dominate the literature, with 18 publications demonstrating their ISR-inducing capacity, primarily from research groups in Belgium (6 papers) and China (4 papers), followed by contributions from Japan, France, Spain, South Korea, Argentina, and Chile. In contrast, investigations into Pseudomonas CLPs remain limited to a single Belgian research group, with publication peaks occurring triennially between 2015 and 2021. The absence of new studies since 2024 highlights an urgent need for broader international engagement in this field.
Substantial gaps persist in our understanding of CLP-mediated ISR. Despite established ISR effects of surfactin/fengycin in wheat (Zymoseptoria tritici) [10], fengycin/iturin in wheat (Fusarium graminearum) [73], and fengycin in tomato (Sclerotinia sclerotiorum pathosystem) [74], further studies are still needed to evaluate CLP efficacy at lower, physiologically relevant concentrations. Furthermore, the current research focus remains narrowly confined to Bacillus and Pseudomonas CLPs, despite the phylogenetic diversity of rhizobacteria capable of CLP production. Expanding investigations to understudied bacterial taxa could reveal novel CLP structures with unique bioactivities.
The dual roles of CLPs as both phytotoxins and immune elicitors are exemplified by contrasting systems. Pathogenic Pseudomonas cichorii SF1-54 produces cichopeptins (Peptin-family CLPs) that contribute to lettuce midrib rot virulence [75], whereas Pseudomonas brassicacearum R401′s brassicapeptin A induces stress symptoms in salt-treated plants despite its non-pathogenic origin [76]. This paradox highlights the context-dependent nature of CLP–plant interactions. This indicates the complexity of plant–microbe interactions, where not all pathogen-derived molecules are purely virulent, as some can stimulate host defenses in specific contexts; dose and environment critically determine whether a CLP functions as a virulence factor or an immune elicitor. Additional studies are required to better understand the links between structure, dose, and the impact of the various CLPs on plant cells in terms of membrane damage and immune activation responses.
Genetic evidence demonstrates distinct jasmonic acid-dependent pathways for CLP-mediated immunity in Arabidopsis. Surfactin induces ISR against Pseudomonas syringae specifically in jar1-1 mutants but not wild-type or npr1 plants. Iturin shows broader efficacy in both wild-type and jar1-1 backgrounds while remaining inactive in npr1 mutants [50]. These findings reveal crucial dependencies on both JAR1-mediated jasmonic acid signaling and NPR1-dependent salicylic acid pathways for different CLP classes. While this review synthesizes current understanding of CLP perception and ISR induction, critical knowledge gaps remain regarding structure–function relationships. Genome-wide transcriptomics and metabolomics would help elucidate the molecular determinants governing these differential responses, particularly how specific CLP structures engage distinct signaling modules. This could be essential for developing targeted crop protection strategies. Previously unresolved questions highlight the need for innovative approaches combining structural biology, membrane biophysics, and plant immunology. This will refine our understanding of the process mediating CLP perception by plant cells via membrane interactions and elucidate the signal transduction cascades activated by different CLP structural classes.
CLPs retain a strong potential for application in plant protection, but no product based on these compounds has been commercialized so far. There are several reasons for this, but relatively low productivity by the bacteria, coupled with high production costs in bioprocesses, certainly constrain such commercial development of low added-value products for agricultural applications [77,78]. Some advances have been made in CLP production and purification [77,78], but further optimization of each step of cost-effective processes at an industrial scale is mandatory for scalable manufacturing and widespread use of these “green compounds”. It first includes enhancing cell productivity in bioreactors via precursor feeding, metabolic engineering, and/or culture media and fermentation condition optimization [79,80,81,82]. CLP recovery and purification from large fermentation volumes, as well as their formulation, usually represent a significant part of total production cost and must also be optimized, taking advantage of membrane- and chromatography-based technologies relying on recent advances [83]. Next, formulated CLP-based products must be further evaluated for their ecotoxicity and for their efficacy under field conditions when applied as a single product or in an IPM (integrated pest management) approach. Indeed, nearly all studies have been conducted under controlled healthy soil conditions, with only one exception [55] considering the complex interplay between CLPs and environmental stressors. Future research must incorporate biotic and abiotic variables to better predict field performance. These advances will bridge the gap between mechanistic understanding and practical implementation of CLP and will significantly enhance our ability to harness these molecules for sustainable crop protection strategies.

Author Contributions

Conceptualization, M.O.; writing—original draft preparation, N.D.; writing—review and editing, M.O., H.D. and N.D. All authors have read and agreed to the published version of the manuscript.

Funding

Work in the M.O. lab is funded by the EU Interreg V France-Wallonie-Vlaanderen portfolio Biocontrol 4.0 (grant No. 731077); the Belgian Funds for Scientific Research (F.R.S.-FNRS) project WEAVE T.0227.24; and by the FEDER project Phenix Biocontrol.

Data Availability Statement

This work is theoretical/review-based; no new data were created or analyzed. Consequently, data sharing is not applicable.

Acknowledgments

We thank Anthony Arguelles-Arias for Figure 1. We are grateful to the China Scholarship Council (CSC) for funding the PhD project of Ning Ding. M.O. thanks the F.R.S.-FNRS in Belgium for his position as research director. H.D. thanks Natural Science Foundation of China for grant number 31772247.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Aci, M.M.; Sidari, R.; Araniti, F.; Lupini, A. Emerging trends in allelopathy: A genetic perspective for sustainable agriculture. Agronomy 2022, 12, 2043. [Google Scholar] [CrossRef]
  2. Emannuel Oliveira Vieira, M.; Vieira Nunes, V.; Costa Calazans, C.; Silva-Mann, R. Unlocking plant defenses: Harnessing the power of beneficial microorganisms for induced systemic resistance in vegetables—A systematic review. Biol. Control. 2024, 188, 105428. [Google Scholar] [CrossRef]
  3. Dimkić, I.; Janakiev, T.; Petrović, M.; Degrassi, G.; Fira, D. Plant-associated Bacillus and Pseudomonas antimicrobial activities in plant disease suppression via biological control mechanisms—A review. Physiol. Mol. Plant Pathol. 2022, 117, 101754. [Google Scholar] [CrossRef]
  4. Pršić, J.; Ongena, M. Elicitors of plant immunity triggered by beneficial bacteria. Front. Plant Sci. 2020, 11, 594530. [Google Scholar] [CrossRef]
  5. Ongena, M.; Jacques, P. Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends Microbiol. 2008, 16, 115–125. [Google Scholar] [CrossRef]
  6. Ajuna, H.B.; Lim, H.-I.; Moon, J.-H.; Won, S.-J.; Choub, V.; Choi, S.-I.; Yun, J.-Y.; Ahn, Y.S. The prospect of antimicrobial peptides from Bacillus species with biological control potential against insect pests and diseases of economic importance in agriculture, forestry and fruit tree production. Biotechnol. Biotechno. Equip. 2024, 38, 2312115. [Google Scholar] [CrossRef]
  7. Maksimov, I.V.; Singh, B.P.; Cherepanova, E.A.; Burkhanova, G.F.; Khairullin, R.M. Prospects and applications of lipopeptide-producing bacteria for plant protection (Review). Appl. Biochem. Microbiol. 2020, 56, 15–28. [Google Scholar] [CrossRef]
  8. Balleux, G.; Höfte, M.; Arguelles-Arias, A.; Deleu, M.; Ongena, M. Bacillus lipopeptides as key players in rhizosphere chemical ecology. Trends Microbiol. 2024, 33, 80–95. [Google Scholar] [CrossRef] [PubMed]
  9. Farace, G.; Fernandez, O.; Jacquens, L.; Coutte, F.; Krier, F.; Jacques, P.; Clément, C.; Barka, E.A.; Jacquard, C.; Dorey, S. Cyclic lipopeptides from Bacillus subtilis activate distinct patterns of defence responses in grapevine. Mol. Plant Pathol. 2015, 16, 177–187. [Google Scholar] [CrossRef]
  10. Mejri, S.; Siah, A.; Coutte, F.; Magnin-Robert, M.; Randoux, B.; Tisserant, B.; Krier, F.; Jacques, P.; Reignault, P.; Halama, P. Biocontrol of the wheat pathogen Zymoseptoria tritici using cyclic lipopeptides from Bacillus subtilis. Environ. Sci. Pollut. Res. 2018, 25, 29822–29833. [Google Scholar] [CrossRef]
  11. De Roo, V.; Verleysen, Y.; Kovács, B.; De Vleeschouwer, M.; Muangkaew, P.; Girard, L.; Höfte, M.; De Mot, R.; Madder, A.; Geudens, N.; et al. An nuclear magnetic resonance fingerprint matching approach for the identification and structural re-evaluation of Pseudomonas Lipopeptides. Microbiol. Spectr. 2022, 10, e0126122. [Google Scholar] [CrossRef]
  12. Götze, S.; Stallforth, P. Structure, properties, and biological functions of nonribosomal lipopeptides from pseudomonads. Nat. Prod. Rep. 2020, 37, 29–54. [Google Scholar] [CrossRef]
  13. Roongsawang, N.; Washio, K.; Morikawa, M. Diversity of nonribosomal peptide synthetases involved in the biosynthesis of lipopeptide biosurfactants. Int. J. Mol. Sci. 2011, 12, 141–172. [Google Scholar] [CrossRef] [PubMed]
  14. Strieker, M.; Tanović, A.; Marahiel, M.A. Nonribosomal peptide synthetases: Structures and dynamics. Curr. Opin. Struct. Biol. 2010, 20, 234–240. [Google Scholar] [CrossRef]
  15. Pilz, M.; Cavelius, P.; Qoura, F.; Awad, D.; Brück, T. Lipopeptides development in cosmetics and pharmaceutical applications: A comprehensive review. Biotechnol. Adv. 2023, 67, 108210. [Google Scholar] [CrossRef] [PubMed]
  16. Kopp, F.; Marahiel, M.A. Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis. Nat. Prod. Rep. 2007, 24, 735. [Google Scholar] [CrossRef] [PubMed]
  17. Dini, S.; Oz, F.; Bekhit, A.E.D.A.; Carne, A.; Agyei, D. Production, characterization, and potential applications of lipopeptides in food systems: A comprehensive review. Compr. Rev. Food Sci. Food Saf. 2024, 23, e13394. [Google Scholar] [CrossRef]
  18. Raaijmakers, J.M.; de Bruijn, I.; Nybroe, O.; Ongena, M. Natural functions of lipopeptides from Bacillus and Pseudomonas: More than surfactants and antibiotics. FEMS Microbiol. Rev. 2010, 34, 1037–1062. [Google Scholar] [CrossRef] [PubMed]
  19. Yang, R.; Lei, S.; Xu, X.; Jin, H.; Sun, H.; Zhao, X.; Pang, B.; Shi, J. Key elements and regulation strategies of NRPSs for biosynthesis of lipopeptides by Bacillus. Appl. Microbiol. Biotechnol. 2020, 104, 8077–8087. [Google Scholar] [CrossRef]
  20. Duban, M.; Cociancich, S.; Leclère, V. Nonribosomal peptide synthesis definitely working out of the rules. Microorganisms 2022, 10, 577. [Google Scholar] [CrossRef]
  21. Backer, R.; Rokem, J.S.; Ilangumaran, G.; Lamont, J.; Praslickova, D.; Ricci, E.; Subramanian, S.; Smith, D.L. Plant growth-promoting rhizobacteria: Context, mechanisms of action, and roadmap to commercialization of biostimulants for sustainable agriculture. Front. Plant Sci. 2018, 9, 1473. [Google Scholar] [CrossRef]
  22. Dobrzyński, J.; Jakubowska, Z.; Kulkova, I.; Kowalczyk, P.; Kramkowski, K. Biocontrol of fungal phytopathogens by Bacillus pumilus. Front. Microbiol. 2023, 14, 1194606. [Google Scholar] [CrossRef] [PubMed]
  23. Miljaković, D.; Marinković, J.; Balešević-Tubić, S. The significance of bacillus spp. in disease suppression and growth promotion of field and vegetable crops. Microorganisms 2020, 8, 1037. [Google Scholar] [CrossRef] [PubMed]
  24. Théatre, A.; Hoste, A.C.R.; Rigolet, A.; Benneceur, I.; Bechet, M.; Ongena, M.; Deleu, M.; Jacques, P. Bacillus sp.: A remarkable source of bioactive lipopeptides. In Biochemical Engineering/Biotechnology; Springer Science and Business Media Deutschland GmbH.: Berlin/Heidelberg, Germany, 2022; pp. 123–179. [Google Scholar] [CrossRef]
  25. Rabbee, M.F.; Hwang, B.S.; Baek, K.H. Bacillus velezensis: A beneficial biocontrol agent or facultative phytopathogen for sustainable agriculture. Agronomy 2023, 13, 840. [Google Scholar] [CrossRef]
  26. Oni, F.E.; Esmaeel, Q.; Onyeka, J.T.; Adeleke, R.; Jacquard, C.; Clement, C.; Gross, H.; Barka, E.A.; Höfte, M. Pseudomonas lipopeptide-mediated biocontrol: Chemotaxonomy and biological activity. Molecules 2022, 27, 372. [Google Scholar] [CrossRef]
  27. Raaijmakers, J.M.; De Bruijn, I.; De Kock, M.J.D. Cyclic lipopeptide production by plant-associated Pseudomonas spp.: Diversity, activity, biosynthesis, and regulation. Mol. Plant Microbe Interact. 2006, 19, 699–710. [Google Scholar] [CrossRef]
  28. Cesa-Luna, C.; Geudens, N.; Girard, L.; De Roo, V.; Maklad, H.R.; Martins, J.C.; Höfte, M.; De Mot, R.; Deveau, A. Charting the lipopeptidome of nonpathogenic Pseudomonas. mSystems 2023, 8, e0098822. [Google Scholar] [CrossRef]
  29. Olishevska, S.; Nickzad, A.; Déziel, E. Bacillus and Paenibacillus secreted polyketides and peptides involved in controlling human and plant pathogens. Appl. Microbiol. Biotechnol. 2019, 103, 1189–1215. [Google Scholar] [CrossRef]
  30. Grady, E.N.; MacDonald, J.; Liu, L.; Richman, A.; Yuan, Z.C. Current knowledge and perspectives of Paenibacillus: A review. Microb. Cell Factories 2016, 15, 203. [Google Scholar] [CrossRef]
  31. Huang, E.; Yousef, A.E. The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage. Appl. Environ. Microbiol. 2014, 80, 2700–2704. [Google Scholar] [CrossRef]
  32. Cochrane, S.A.; Vederas, J.C. Lipopeptides from Bacillus and Paenibacillus spp.: A gold mine of antibiotic candidates. Med. Res. Rev. 2016, 36, 4–31. [Google Scholar] [CrossRef]
  33. Clements, T.; Ndlovu, T.; Khan, S.; Khan, W. Biosurfactants produced by Serratia species: Classification, biosynthesis, production and application. Appl. Microbiol. Biotechnol. 2019, 103, 589–602. [Google Scholar] [CrossRef]
  34. Thies, S.; Santiago-Schübel, B.; Kovačić, F.; Rosenau, F.; Hausmann, R.; Jaeger, K.E. Heterologous production of the lipopeptide biosurfactant serrawettin W1 in Escherichia coli. J. Biotechnol. 2014, 181, 27–30. [Google Scholar] [CrossRef] [PubMed]
  35. Heath, E.C.; Hurwitz, J.; Horecker, B.L.; Ginsburg, A.; Olsen, C.W. Serratamolide, a metabolic product of Serratia. J. Am. Chem. Soc. 1961, 83, 4107–4108. [Google Scholar] [CrossRef]
  36. Ganley, J.G.; Carr, G.; Ioerger, T.R.; Sacchettini, J.C.; Clardy, J.; Derbyshire, E.R. Discovery of antimicrobial lipodepsipeptides produced by a Serratia sp. within mosquito microbiomes. ChemBioChem 2018, 19, 1590–1594. [Google Scholar] [CrossRef] [PubMed]
  37. Kitani, S.; Yoshida, M.; Boonlucksanawong, O.; Panbangred, W.; Anuegoonpipat, A.; Kurosu, T.; Ikuta, K.; Igarashi, Y.; Nihira, T. Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp. J. Antibiot. 2018, 71, 662–666. [Google Scholar] [CrossRef]
  38. Kügler, J.H.; Le Roes-Hill, M.; Syldatk, C.; Hausmann, R. Surfactants tailored by the class Actinobacteria. Front. Microbiol. 2015, 6, 212. [Google Scholar] [CrossRef]
  39. Zhang, S.; Chen, Y.; Zhu, J.; Lu, Q.; Cryle, M.J.; Zhang, Y.; Yan, F. Structural diversity, biosynthesis, and biological functions of lipopeptides from Streptomyces. Nat. Prod. Rep. 2023, 40, 557–594. [Google Scholar] [CrossRef]
  40. Aftab, U.; Sajid, I. Antitumor peptides from Streptomyces sp. SSA 13, isolated from Arabian Sea. Int. J. Pept. Res. Ther. 2017, 23, 199–211. [Google Scholar] [CrossRef]
  41. Ongena, M.; Jourdan, E.; Adam, A.; Paquot, M.; Brans, A.; Joris, B.; Arpigny, J.; Thonart, P. Surfactin and fengycin lipopeptides of Bacillus subtilis as elicitors of induced systemic resistance in plants. Environ. Microbiol. 2007, 9, 1084–1090. [Google Scholar] [CrossRef]
  42. García-Gutiérrez, L.; Zeriouh, H.; Romero, D.; Cubero, J.; de Vicente, A.; Pérez-García, A. The antagonistic strain Bacillus subtilis UMAF6639 also confers protection to melon plants against cucurbit powdery mildew by activation of jasmonate- and salicylic acid-dependent defence responses. Microb. Biotechnol. 2013, 6, 264–274. [Google Scholar] [CrossRef] [PubMed]
  43. Cawoy, H.; Mariutto, M.; Henry, G.; Fisher, C.; Vasilyeva, N.; Thonart, P.; Dommes, J.; Ongena, M. Plant defense stimulation by natural isolates of Bacillus depends on efficient surfactin production. Mol. Plant Microbe Interact. 2014, 27, 87–100. [Google Scholar] [CrossRef] [PubMed]
  44. Yamamoto, S.; Shiraishi, S.; Suzuki, S. Are cyclic lipopeptides produced by Bacillus amyloliquefaciens S13-3 responsible for the plant defence response in strawberry against Colletotrichum gloeosporioides? Lett. Appl. Microbiol. 2015, 60, 379–386. [Google Scholar] [CrossRef]
  45. Debois, D.; Fernandez, O.; Franzil, L.; Jourdan, E.; de Brogniez, A.; Willems, L.; Clément, C.; Dorey, S.; De Pauw, E.; Ongena, M. Plant polysaccharides initiate underground crosstalk with bacilli by inducing synthesis of the immunogenic lipopeptide surfactin. Environ. Microbiol. Rep. 2015, 7, 570–582. [Google Scholar] [CrossRef] [PubMed]
  46. Wu, G.; Liu, Y.; Xu, Y.; Zhang, G.; Shen, Q.; Zhang, R. Exploring elicitors of the beneficial rhizobacterium Bacillus amyloliquefaciens SQR9 to induce plant systemic resistance and their interactions with plant signaling pathways. Mol. Plant Microbe Interact. 2018, 31, 560–567. [Google Scholar] [CrossRef]
  47. Rodríguez, J.; Tonelli, M.L.; Figueredo, M.S.; Ibáñez, F.; Fabra, A. The lipopeptide surfactin triggers induced systemic resistance and priming state responses in Arachis hypogaea L. Eur. J. Plant Pathol. 2018, 152, 845–851. [Google Scholar] [CrossRef]
  48. Hoff, G.; Arias, A.A.; Boubsi, F.; Pršić, J.; Meyer, T.; Ibrahim, H.M.M.; Steels, S.; Luzuriaga, P.; Legras, A.; Franzil, L.; et al. Surfactin stimulated by pectin molecular patterns and root exudates acts as a key driver of the Bacillus-plant mutualistic interaction. mBio 2021, 12, e01774-21. [Google Scholar] [CrossRef]
  49. Stoll, A.; Salvatierra-Martínez, R.; González, M.; Araya, M. The role of surfactin production by Bacillus velezensis on colonization, biofilm formation on tomato root and leaf surfaces and subsequent protection (ISR) against Botrytis cinerea. Microorganisms 2021, 9, 2251. [Google Scholar] [CrossRef]
  50. Altrão, C.S.; Kaneko, M.; Shiina, S.; Kajikawa, A.; Shinohara, H.; Yokota, K. Insights on suppression of bacterial leaf spot by Bacillus cyclic lipopeptides via induced resistance in Arabidopsis thaliana. J. Gen. Plant Pathol. 2022, 88, 259–263. [Google Scholar] [CrossRef]
  51. Alleluya, V.K.; Arias, A.A.; Ribeiro, B.; De Coninck, B.; Helmus, C.; Delaplace, P.; Ongena, M. Bacillus lipopeptide-mediated biocontrol of peanut stem rot caused by Athelia rolfsii. Front. Plant Sci. 2023, 14, 1069971. [Google Scholar] [CrossRef]
  52. Zhou, L.; Song, C.; Muñoz, C.Y.; Kuipers, O.P. Bacillus cabrialesii BH5 protects tomato plants against Botrytis cinerea by production of specific antifungal compounds. Front. Microbiol. 2021, 12, 707609. [Google Scholar] [CrossRef]
  53. He, P.; Cui, W.; Munir, S.; He, P.; Huang, R.; Li, X.; Wu, Y.; Wang, Y.; Yang, J.; Tang, P.; et al. Fengycin produced by Bacillus subtilis XF-1 plays a major role in the biocontrol of Chinese cabbage clubroot via direct effect and defense stimulation. J. Cell. Physiol. 2023, 239, e30991. [Google Scholar] [CrossRef]
  54. Park, K.; Park, Y.-S.; Ahamed, J.; Dutta, S.; Ryu, H.; Lee, S.-H.; Balaraju, K.; Manir, M.; Moon, S.-S.; Charles, M. Elicitation of induced systemic resistance of chili pepper by iturin A analogs derived from Bacillus vallismortis EXTN-1. Can. J. of Plant Sci. 2016, 96, 564–570. [Google Scholar] [CrossRef]
  55. Lam, V.B.; Meyer, T.; Arias, A.A.; Ongena, M.; Oni, F.E.; Höfte, M. Bacillus cyclic lipopeptides iturin and fengycin control rice blast caused by Pyricularia oryzae in potting and acid sulfate soils by direct antagonism and induced systemic resistance. Microorganisms 2021, 9, 1441. [Google Scholar] [CrossRef] [PubMed]
  56. Tran, H.; Ficke, A.; Asiimwe, T.; Höfte, M.; Raaijmakers, J.M. Role of the cyclic lipopeptide massetolide a in biological control of Phytophthora infestans and in colonization of tomato plants by Pseudomonas fluorescens. New Phytol. 2007, 175, 731–742. [Google Scholar] [CrossRef]
  57. Ma, Z.; Hoang Hua, G.K.H.; Ongena, M.; Höfte, M. Role of phenazines and cyclic lipopeptides produced by Pseudomonas sp. CMR12a in induced systemic resistance on rice and bean. Environ. Microbiol. Rep. 2016, 8, 896–904. [Google Scholar] [CrossRef]
  58. Ma, Z.; Ongena, M.; Höfte, M. The cyclic lipopeptide orfamide induces systemic resistance in rice to Cochliobolus miyabeanus but not to Magnaporthe oryzae. Plant Cell Rep. 2017, 36, 1731–1746. [Google Scholar] [CrossRef]
  59. Omoboye, O.O.; Oni, F.E.; Batool, H.; Yimer, H.Z.; De Mot, R.; Höfte, M. Pseudomonas cyclic lipopeptides suppress the rice blast fungus Magnaporthe oryzae by induced resistance and direct antagonism. Front. Plant Sci. 2019, 10, 901. [Google Scholar] [CrossRef]
  60. Luo, C.; Zhou, H.; Zou, J.; Wang, X.; Zhang, R.; Xiang, Y.; Chen, Z. Bacillomycin L and surfactin contribute synergistically to the phenotypic features of Bacillus subtilis 916 and the biocontrol of rice sheath blight induced by Rhizoctonia solani. Appl. Microbiol. Biotechnol. 2015, 99, 1897–1910. [Google Scholar] [CrossRef]
  61. Khan, Q.; Huang, X.; He, Z.; Wang, H.; Chen, Y.; Xia, G.; Wang, Y.; Lang, F.; Zhang, Y. An insight into conflict and collaboration between plants and microorganisms. Chem. Biol. Technol. Agric. 2024, 11, 161. [Google Scholar] [CrossRef]
  62. Balleza, D.; Alessandrini, A.; Beltrán García, M.J. Role of lipid composition, physicochemical interactions, and membrane mechanics in the molecular actions of microbial cyclic lipopeptides. J. Membr. Biol. 2019, 252, 131–157. [Google Scholar] [CrossRef] [PubMed]
  63. Aranda, F.J.; Teruel, J.A.; Ortiz, A. Recent advances on the interaction of glycolipid and lipopeptide biosurfactants with model and biological membranes. Curr. Opin. Colloid Interface Sci. 2023, 68, 101748. [Google Scholar] [CrossRef]
  64. Nasir, M.N.; Besson, F. Interactions of the antifungal mycosubtilin with ergosterol-containing interfacial monolayers. Biochim. Biophys. Acta Biomembr. 2012, 1818, 1302–1308. [Google Scholar] [CrossRef] [PubMed]
  65. Deleu, M.; Paquot, M.; Nylander, T. Fengycin interaction with lipid monolayers at the air-aqueous interface—Implications for the effect of fengycin on biological membranes. J. Colloid Interface Sci. 2005, 283, 358–365. [Google Scholar] [CrossRef] [PubMed]
  66. Gilliard, G.; Furlan, A.L.; Smeralda, W.; Pršić, J.; Deleu, M. Added value of biophysics to study lipid-driven biological processes: The case of surfactins, a class of natural amphiphile molecules. Int. J. Mol. Sci. 2022, 23, 13831. [Google Scholar] [CrossRef]
  67. Kawagoe, Y.; Shiraishi, S.; Kondo, H.; Yamamoto, S.; Aoki, Y.; Suzuki, S. Cyclic lipopeptide iturin A structure-dependently induces defense response in Arabidopsis plants by activating SA and JA signaling pathways. Biochem. Biophys. Res. Commun. 2015, 460, 1015–1020. [Google Scholar] [CrossRef]
  68. Henry, G.; Deleu, M.; Jourdan, E.; Thonart, P.; Ongena, M. The bacterial lipopeptide surfactin targets the lipid fraction of the plant plasma membrane to trigger immune-related defence responses. Cell. Microbiol. 2011, 13, 1824–1837. [Google Scholar] [CrossRef]
  69. Hamley, I.W. Lipopeptides: From self-assembly to bioactivity. Chem. Commun. 2015, 51, 8574–8583. [Google Scholar] [CrossRef]
  70. Phelan, A.; Cobb, S.; Gimenez-Ibanez, D.; Murphy, C.D. Production of fluorinated fengycins in Bacillus spp. Access Microbiol. 2019, 1. [Google Scholar] [CrossRef]
  71. Gimenez, D.; Phelan, A.; Murphy, C.D.; Cobb, S.L. Fengycin A analogues with enhanced chemical stability and antifungal properties. Org. Lett. 2021, 23, 4672–4676. [Google Scholar] [CrossRef]
  72. Xie, S.; Jiang, H.; Ding, T.; Xu, Q.; Chai, W.; Cheng, B. Bacillus amyloliquefaciens FZB42 represses plant miR846 to induce systemic resistance via a jasmonic acid-dependent signalling pathway. Mol. Plant Pathol. 2018, 19, 1612–1623. [Google Scholar] [CrossRef]
  73. Yuan, Q.; Yang, P.; Liu, Y.; Tabl, K.M.; Guo, M.; Zhang, J.; Wu, A.; Liao, Y.; Huang, T.; He, W. Iturin and fengycin lipopeptides inhibit pathogenic Fusarium by targeting multiple components of the cell membrane and their regulative effects in wheat. J. Integr. Plant Biol. 2025, 67, 2187–2197. [Google Scholar] [CrossRef]
  74. Farzand, A.; Moosa, A.; Zubair, M.; Khan, A.R.; Massawe, V.C.; Tahir, H.A.S.; Sheikh, T.M.M.; Ayaz, M.; Gao, X. Suppression of Sclerotinia sclerotiorum by the induction of systemic resistance and regulation of antioxidant pathways in tomato using fengycin produced by Bacillus amyloliquefaciens FZB42. Biomolecules 2019, 9, 613. [Google Scholar] [CrossRef] [PubMed]
  75. Huang, C.J.; Pauwelyn, E.; Ongena, M.; Bleyaert, P.; Höfte, M. Both GacS-regulated lipopeptides and the type three secretion system contribute to Pseudomonas cichorii induced necrosis in lettuce and chicory. Res. Microbiol. 2024, 176, 104249. [Google Scholar] [CrossRef] [PubMed]
  76. Getzke, F.; Wang, L.; Chesneau, G.; Böhringer, N.; Mesny, F.; Denissen, N.; Wesseler, H.; Adisa, P.T.; Marner, M.; Schulze-Lefert, P.; et al. Physiochemical interaction between osmotic stress and a bacterial exometabolite promotes plant disease. Nat. Commun. 2024, 15, 4438. [Google Scholar] [CrossRef] [PubMed]
  77. Saiyam, D.; Dubey, A.; Malla, M.A.; Kumar, A. Lipopeptides from Bacillus: Unveiling biotechnological prospects—Sources, properties, and diverse applications. Braz. J. Microbiol. 2024, 55, 281–295. [Google Scholar] [CrossRef]
  78. Penha, R.O.; Vandenberghe, L.P.S.; Faulds, C.; Soccol, V.T.; Soccol, C.R. Bacillus lipopeptides as powerful pest control agents for a more sustainable and healthy agriculture: Recent studies and innovations. Planta 2020, 251, 70. [Google Scholar] [CrossRef]
  79. Théatre, A.; Cano-Prieto, C.; Bartolini, M.; Laurin, Y.; Deleu, M.; Niehren, J.; Fida, T.; Gerbinet, S.; Alanjary, M.; Medema, M.H.; et al. The surfactin-like lipopeptides from Bacillus spp.: Natural biodiversity and synthetic biology for a broader application range. Front. Bioeng. Biotechnol. 2021, 9, 623701. [Google Scholar] [CrossRef]
  80. Coutte, F.; Niehren, J.; Dhali, D.; John, M.; Versari, C.; Jacques, P. Modeling leucine’s metabolic pathway and knockout prediction improving the production of surfactin, a biosurfactant from Bacillus subtilis. Biotechnol. J. 2015, 10, 1216–1234. [Google Scholar] [CrossRef]
  81. Dhali, D.; Coutte, F.; Arias, A.A.; Auger, S.; Bidnenko, V.; Chataigné, G.; Lalk, M.; Niehren, J.; de Sousa, J.; Versari, C.; et al. Genetic engineering of the branched fatty acid metabolic pathway of Bacillus subtilis for the overproduction of surfactin C14 isoform. Biotechnol. J. 2017, 12, 1600574. [Google Scholar] [CrossRef]
  82. Guez, J.S.; Vassaux, A.; Larroche, C.; Jacques, P.; Coutte, F. New continuous process for the production of lipopeptide biosurfactants in foam overflowing bioreactor. Front. Bioeng. Biotechnol. 2021, 9, 678469. [Google Scholar] [CrossRef]
  83. Vassaux, A.; Rannou, M.; Peers, S.; Daboudet, T.; Jacques, P.; Coutte, F. Impact of the purification process on the spray-drying performances of the three families of lipopeptide biosurfactant produced by Bacillus subtilis. Front. Bioeng. Biotechnol. 2021, 9, 815337. [Google Scholar] [CrossRef]
Figure 1. Modular organization and main steps in the nonribosomal biosynthesis of surfactin as a model CLP. (A) Modules and main steps in biosynthesis of nonribosomal peptides. Adenylation (A), peptidyl carrier protein (CP), and condensation (C) domains act as an assembly line. The thioesterase (TE) domain of the termination module cleaves the thioester bond and releases the peptide. (B) Activation of the CP domain of the NRPS, where the serine residue of unactivated PCP (apo-PCP) has to be combined with coenzyme A, thanks to the 4′phosphopanteteinyl transferase, encoded by the sfp gene, to be able to play its carrier role (holo-PCP). (C) Representation of the whole surfactin assembly line.
Figure 1. Modular organization and main steps in the nonribosomal biosynthesis of surfactin as a model CLP. (A) Modules and main steps in biosynthesis of nonribosomal peptides. Adenylation (A), peptidyl carrier protein (CP), and condensation (C) domains act as an assembly line. The thioesterase (TE) domain of the termination module cleaves the thioester bond and releases the peptide. (B) Activation of the CP domain of the NRPS, where the serine residue of unactivated PCP (apo-PCP) has to be combined with coenzyme A, thanks to the 4′phosphopanteteinyl transferase, encoded by the sfp gene, to be able to play its carrier role (holo-PCP). (C) Representation of the whole surfactin assembly line.
Plants 14 02644 g001
Figure 2. Chemical structures of main CLPs with ISR-inducing activity. The figure represents the mentioned CLPs (surfactin, fengycin A, iturin A, massetolide C, WLIP, bacillomycin D, sessilin A, and orfamide A) drawn with ChemSketch 12.01.
Figure 2. Chemical structures of main CLPs with ISR-inducing activity. The figure represents the mentioned CLPs (surfactin, fengycin A, iturin A, massetolide C, WLIP, bacillomycin D, sessilin A, and orfamide A) drawn with ChemSketch 12.01.
Plants 14 02644 g002
Table 1. Simplified primary chemical structures of CLPs reported to trigger ISR in plants. aThr refers to allo-threonine. The underlined AA residues refer to the AAs in the cyclic peptide ring. The red color marks D-AAs, and the rest are L-AAs. So far, the determination of the AAs of sessilin A to be L or D form is not clear.
Table 1. Simplified primary chemical structures of CLPs reported to trigger ISR in plants. aThr refers to allo-threonine. The underlined AA residues refer to the AAs in the cyclic peptide ring. The red color marks D-AAs, and the rest are L-AAs. So far, the determination of the AAs of sessilin A to be L or D form is not clear.
CLPsFAAA
123456789101112131415161718
SurfactinsC12-C17GluLeuLeuValAspLeuLeu///////////
FengycinsC14-C18GluOrnTyraThrGluAlaProGlnTyrIle////////
IturinsC14-C17AsnTyrAsnGlnProAsnSer///
BacillomycinsC14-C17AsnTyrAsnProGluSerThr///
Massetolide AC10LeuGluaThraIleLeuSerLeuSerIle/////////
WLIPC10LeuGluaThrValLeuSerLeuSerIle/////////
Sessilin AC8DhbProSerLeuValGlnLeuValValGlnLeuValDhbThrIleHseDabLys
Orfamide AC14LeuGluaThrIleLeuSerLeuLeuSerVal////////
Table 2. CLPs reported to trigger ISR in plants.
Table 2. CLPs reported to trigger ISR in plants.
CLP NameStrain SpeciesPlantPathogenMethodReference
SurfactinBacillus subtilisBeanBotrytis cinereaPure compound; mutants[41]
SurfactinBacillus subtilisTomatoBotrytis cinereaMutants[41]
SurfactinBacillus subtilisMelonPodosphaera fuscaMutant; mutant and commercial C15 surfactin; commercial C15 surfactin[42]
SurfactinBacillus velezensis; Bacillus subtilis; Paenibacillus polymyxaTomatoBotrytis cinereaStrains producing different amounts of surfactin[43]
Surfactin/StrawberryColletotrichum gloeosporioidesPure compound[44]
SurfactinBacillus subtilisGrapevineBotrytis cinereaPure compound[9]
SurfactinBacillus velezensisArabidopsisBotrytis cinereaPure compound[45]
SurfactinBacillus amyloliquefaciens SQR9ArabidopsisBotrytis cinereaMutant[46]
SurfactinBacillus amyloliquefaciens SQR9ArabidopsisPseudomonas syringaeMutant[46]
SurfactinBacillus subtilisPeanutSclerotium rolfsiiPure compound[47]
SurfactinBacillus velezensisTobaccoBotrytis cinereaPure compound[48]
Surfactin/TomatoBotrytis cinereaCommercial compound[49]
Surfactin/ArabidopsisPseudomonas syringaeCommercial compound[50]
Surfactin/Arabidopsis jar1-1Pseudomonas syringaeCommercial compound[50]
SurfactinBacillus subtilisPeanutAthelia rolfsiiPure compound[51]
FengycinBacillus subtilisTomatoBotrytis cinereaMutant[41]
FengycinBacillus velezensisArabidopsisPseudomonas syringaeMutant[46]
Fengycin HBacillus cabrialesiiTomatoBotrytis cinereaPure compound[52]
FengycinBacillus subtilisChinese cabbagePlasmodiophora brassicaeMutant[53]
Iturin A /StrawberryColletotrichum gloeosporioidesCommercial compound[44]
Iturin ABacillus vallismortisChili pepperPhytophthora capsiciPure compound[54]
Bacillomycin DBacillus velezensisArabidopsisPseudomonas syringaeMutant[46]
Bacillomycin DBacillus velezensisArabidopsisBotrytis cinereaMutant[46]
Iturin ABacillus subtilisArabidopsisPseudomonas syringaePure compound[50]
Iturin ABacillus subtilisArabidopsis jar1-1Pseudomonas syringaePure compound[50]
Surfactin and fengycinBacillus subtilisBeanBotrytis cinereaMutant[41]
Fengycin and iturinBacillus velezensisRicePyricularia oryzaeMutants[55]
Surfactin, fengycin, and iturinBacillus velezensisRicePyricularia oryzaeMutants[55]
Massetolide APseudomonas fluorescensTomatoPhytophthora infestansMutant; pure compound[56]
SessilinPseudomonas sessilinigenesBeanRhizoctonia solaniMutants; pure compound[57]
OrfamidePseudomonas sessilinigenesBeanRhizoctonia solaniMutants; pure compound[57]
OrfamidePseudomonas protegensRiceCochliobolus miyabeanusPure compound; mutant[58]
WLIPPseudomonas putidaRiceMagnaporthe oryzaeMutants[59]
Sessilin and orfamidePseudomonas sessilinigenesBeanRhizoctonia solaniMutants[57]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ding, N.; Dong, H.; Ongena, M. Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens. Plants 2025, 14, 2644. https://doi.org/10.3390/plants14172644

AMA Style

Ding N, Dong H, Ongena M. Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens. Plants. 2025; 14(17):2644. https://doi.org/10.3390/plants14172644

Chicago/Turabian Style

Ding, Ning, Hansong Dong, and Marc Ongena. 2025. "Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens" Plants 14, no. 17: 2644. https://doi.org/10.3390/plants14172644

APA Style

Ding, N., Dong, H., & Ongena, M. (2025). Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens. Plants, 14(17), 2644. https://doi.org/10.3390/plants14172644

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop